Prefilled Syringes to 2018: Devices, Drugs, Markets, Players and Prospects

Introduction

Greystone Research Associates is pleased to announce the publication of a new market study. Prefilled Syringes to 2018: Devices, Drugs, Markets, Players, Prospects is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prefilled syringes and injectable devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Prefilled Syringes and the Evolving Landscape for Injectable Drugs

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naive users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

• Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics
• Examines supply chain and ecosystem structure and relationships and their impact on the competitive landscape
• Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
• Analyzes design factors, material selection issues, technologies and market development issues
• Provides market data and forecasts to 2018
• Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
• Assesses the importance of pharma-device alliances and design partnerships on prefilled syringe products
• Evaluates the impact of economic, technology, and regulatory factors

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

• Competitive Landscape
• The Device Manufacturing Universe
• Supply Chain Dynamics
• Supply Chain Structure
• Supplier Relationships and Supply Risk
• Supplier Integration
• Captive Capacity vs CMOs
• Demand Drivers
• Drug Discovery and Development Trends
• Patient and Caregiver Sentiment
• Diseases and Indications
• Patient Demographics

The Prefilled Syringe Ecosystem and Supply Chain

• Materials and Components
  • Evolving Technology
  • Alliances & Relationships
• Syringe Manufacturers
  • Technology/Capabilities
  • Geographic Reach
  • Barriers to Entry
• CMO's - Beyond Fill & Finish
  • Value-added Services
  • Market Proximity
  • CMO Evolution
• Testing, Services and Validation

Prefilled Syringes - Design Factors

• Drug Stability and Shelf Life
• Material Selection Issues
• Point-of-Use Reconstitution
• Caregiver Safety
• Needle Configuration Strategies
• Human Engineering/Ergonomics

Prefilled Syringes - Commercial Devices

• Prefillable Therapeutic Injectables
• Glass Prefillable Syringes
• Plastic Prefillable Syringes
• Ready-to-Fill Safety Syringes

Specialty Prefillable Syringes

• Flush Syringes
• Diluent Syringes
• Imaging Agent Syringes

Competing Prefilled Devices

• Bundled PFS + Autoinjector
• Prefilled Pen Injectors
• Prefilled Needle-free Injectors

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

• Anaphylaxis
• Anticoagulants
• Autoimmune Diseases
• Emergency Medicine
• Hepatitis
• Hematopoietics and Related Erythropoiesis Stimulating Proteins
• Metabolic Diseases
• Neurology
• Reproductive Health
• Vaccines

Non-API Prefilled Syringe Segments

• Catheterization
• Reconstitution
• Diagnostic Imaging

Market Factors

• Self-Administration and Patient Compliance
• Insurance, Reimbursement, and Managed Care
• Regulatory Guidance and Product Approvals
• The Evolving PFS Ecosystem

Company Profiles

Prefilled Syringes to 2018: Devices, Drugs, Markets, Players and Prospects published by Greystone Research Associates in March 1, 2013. This report price starts from US $ 3850.

The contents of this page may be different from the latest version. Please contact us for details.